retatrutide phase 2 trial type 2 diabetes results 2024 💉 may be redefining obesity treatment. New data from TRIUMPH-1 showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Triple hormone receptor agonist retatrutide

Store vials upright to minimize contact with the rubber stopper, and keep them away from the freezer compartment in your refrigerator to avoid accidental freezing

A note to Novo: Novo, thanks for the consolation, but in light of Zepbound's clear superiority, Wegovy is a $200 a month drug, not $499

Always run the calculation first

Many participants experienced gastrointestinal side effects including abdominal pain, diarrhoea, nausea and vomiting, acid reflux and constipation, which varied in severity

Theyll have more choice.

The group formed on Telegram after users received vials from the same vendor which they judged to be from the same batch based on the colour of the caps